Shares of Viavi Solutions jumped 9.2% to $36.35 after the wireless-testing specialist unveiled what it calls the industry's first lab tool purpose-built to simulate real-world radio conditions for next-generation 6G and Wi-Fi 7/8 networks. A broader tech rally — fueled by strong AI-infrastructure earnings and an in-line July CPI that boosted rate-cut hopes — amplified the move, but the product news gave investors a concrete reason to bid up a stock already riding a powerful acquisition story.

• A $425 Million Acquisition Is Starting to Pay Off. The new platform is the first upgrade to the Vertex channel emulation line since Viavi acquired Spirent Communications' high-speed Ethernet, network security, and channel emulation business — a deal closed in October 2025 for $425 million in cash.

That transaction was expected to add roughly $180 million in annual revenue to Viavi's network-testing segment. This launch signals Viavi is not just digesting the acquisition but actively building on it to target a market that barely existed when the deal was struck.

• The 6G Testing Market Is Growing Fast — But Still Small. The global 6G testing equipment market was valued at $624 million in 2025 and is projected to reach $4.2 billion by 2035, growing at roughly 20% a year.

Viavi is listed alongside Keysight Technologies, Anritsu, and Rohde & Schwarz as a key player. Being first matters in test-and-measurement because chipmakers and equipment vendors lock in tool suppliers early in a development cycle. Still, 6G standards remain years from completion — meaning near-term revenue from this product will be modest.

• The Numbers Behind the Optimism. Viavi posted Q4 fiscal 2026 revenue of $443.1 million, up 52.5% year over year, and management guided Q1 fiscal 2027 revenue to $450–$460 million.

Full-year fiscal 2026 revenue hit $1.5 billion, a 40% jump, though Viavi still reported a GAAP net loss of $30.4 million as integration and interest costs from a $600 million term loan weigh on the bottom line.

• An Insider Cashed Out Near the High. An executive sold 1,595 shares on August 10 at $37.37 each — slightly above the market close — a routine move, but one that reminds investors the stock has risen sharply and insiders are taking some chips off the table. The question now: can Viavi convert first-mover status into durable revenue before competitors catch up?